HomeOpen Access NewsCoronavirus

Coronavirus

Subscribe to Updates

Stanford creates virtual scientist to accelerate drug and vaccine discovery

Pharma
Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.

Lung blood vessels show alteration from COVID-19 in new X-ray

Research & Innovation
The brightest ever X-ray shows damage caused by COVID-19 in the lungs’ smallest blood vessels, released by a special particle accelerator.

European Commission addresses G20 and COP26 summit objectives

Government
The European Commission President addresses the goals set for the G20 and COP26 summits, aiming to tackle the pandemic, climate change and the economy.

WHO approves Bharat Biotech Covaxin for emergency use

Research & Innovation
Today (3 November) the World Health Organisation has approved the COVID vaccine, Bharat Biotech Covaxin, for Emergency Use Authorisation.

Did COVID-19 solitude benefit well-being?

Mental Health
Study finds solitude during the pandemic has positive benefits on well-being, creating feelings of self-growth and competence.

Scientists say fully vaccinated people can transmit Delta variant

Health & Social Care
A UK study, published in The Lancet Infectious Diseases, found that fully vaccinated people can still catch and transmit the Delta variant of COVID.

New “clickable” COVID vaccine patch in early stages of testing

Research & Innovation
The University of Texas is creating a COVID vaccine patch, which can protect against the virus - without the use of a needle.

Scientists say Pfizer third dose decreases COVID death risk by 81%

Health & Social Care
According to a real-world study involving over 700,000 people, a Pfizer third dose can decrease COVID death risk by as much as 81%.

Fluvoxamine can cut COVID-19 hospitalisations by 30%

Pharma
Fluvoxamine, a cheap repurposed drug, can cut COVID-19 hospitalisations by up to 30%, according to a new study.

How businesses can cope with the effects of Long Covid in the workplace

Workplace
Gill Nye, Executive Head of HR at Cantium Business Solutions, explores the effect long covid will have on the workplace, with a particular focus on occupational health provision.

Are you eligible for the COVID-19 booster jab?

Health & Social Care
Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.

Document leak finds “Plan B” could cost UK economy £18 billion

Government
According to leaked documents, the UK Government is reluctant to use "Plan B" because COVID restrictions may cost the economy up to £18 billion.

Third of leukaemia patients show no COVID-19 antibody response

Cancer Research
According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.

Economic inequality in the US: Building back better for whom?

Government
Jeronim Capaldo and Richard Kozul-Wright, from the United Nations Conference on Trade and Development (UNCTAD), examine economic inequality in the United States.

UK creates deal for 480,000 doses of Merck COVID pill

Health & Social Care
The Merck COVID pill, molnupiravir, cuts risk of death by 50% - now, the UK have secured 480,000 doses for late 2021.

Risk of pregnancy loss not associated with COVID-19 vaccines

Women's Health
According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.

Scientists find vaccinated teens 90% less likely to catch COVID

Health & Social Care
The real-world study finds that fully vaccinated teenagers are 90% less likely to catch COVID, according to an analysis of over 90,000 people.
1...121314...72Page 13 of 72

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd